LEADER 02676oas 2200997 a 450 001 9910985991103321 005 20251119213018.0 011 $a1744-8360 035 $a(OCoLC)50318323 035 $a(CONSER) 2006242306 035 $a(CKB)111058298582004 035 $a(EXLCZ)99111058298582004 100 $a20020807a20019999 sy 101 0 $aeng 135 $aurunu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aExpert review of neurotherapeutics 210 $aLondon $cFuture Drugs Ltd.$dİ2001- 210 3 $aLondon $cInforma UK 300 $aRefereed/Peer-reviewed 311 08$a1473-7175 606 $aNeuropsychopharmacology$vPeriodicals 606 $aNeuropharmacology$vPeriodicals 606 $aCentral Nervous System Diseases$xdrug therapy 606 $aMental Disorders$xdrug therapy 606 $aNeurocognitive Disorders$xdrug therapy 606 $aCentral Nervous System$xdrug effects 606 $aNeuropharmacology 606 $aNeuropharmacology$2fast$3(OCoLC)fst01036458 606 $aNeuropsychopharmacology$2fast$3(OCoLC)fst01036504 606 $aNeuropsychopharmacologie$vPe?riodiques 606 $aNeuropharmacologie$vPe?riodiques 606 $aNeuropharmacologie 608 $aPeriodical. 608 $aReview. 608 $aPeriodicals.$2fast 615 0$aNeuropsychopharmacology 615 0$aNeuropharmacology 615 2$aCentral Nervous System Diseases$xdrug therapy. 615 2$aMental Disorders$xdrug therapy. 615 2$aNeurocognitive Disorders$xdrug therapy. 615 2$aCentral Nervous System$xdrug effects. 615 2$aNeuropharmacology. 615 7$aNeuropharmacology. 615 7$aNeuropsychopharmacology. 615 6$aNeuropsychopharmacologie 615 6$aNeuropharmacologie 615 6$aNeuropharmacologie. 801 0$bAGY 801 1$bAGY 801 2$bOCLCQ 801 2$bMYG 801 2$bOCLCQ 801 2$bUKMGB 801 2$bOCLCQ 801 2$bOCLCF 801 2$bMYG 801 2$bOCLCQ 801 2$bMOW 801 2$bOCLCO 801 2$bAU@ 801 2$bOCLCO 801 2$bWYU 801 2$bOCLCO 801 2$bOCLCA 801 2$bCNTRU 801 2$bOCLCO 801 2$bOCLCA 801 2$bOCLCQ 801 2$bIOY 801 2$bORU 801 2$bSRU 801 2$bVLY 801 2$bOCLCL 801 2$bUX0 801 2$bLVT 801 2$bUX1 801 2$bNLE 801 2$bAPUMS 801 2$bUEJ 906 $aJOURNAL 912 $a9910985991103321 996 $aExpert review of neurotherapeutics$92381179 997 $aUNINA